logo-loader

LexaGene prepares for commercialization of their newly named device MiQLab

Published: 12:18 13 Jul 2020 EDT

LexaGene Holdings (CVE: LXG-OTCQB: LXXGF) CEO Dr Jack Regan joined Steve Darling from Proactive Vancouver with news the company has announced the name and look of their new genetic analyzers for rapid pathogen detection. It’s called MiQLab 

Regan told Proactive why that name when they plan on having the units available on the market.

Xeris Biopharma Surpasses 2023 Expectations with Strategic Moves Poised for...

Xeris Biopharma CEO Paul Edick joined Steve Darling from Proactive to share news the company had a successful 2023, with a final tally of 164 million USD, which is at the upper end of their forecast. The company concluded the year with 72 million USD in cash, surpassing their initial projections...

15 hours, 23 minutes ago